Health Condition 1: null- Acne Scarring
Conditions
Interventions
Intervention1: Autologous Human Platelet Lysate (HPL): Subjects will receive a single injection of Autologous Human Platelet Lysate (5ml) for acne scarring.
Intervention2: Autologous Human Platelet Ly
Sponsors
Kasiak Research Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects (male and female), aged 18 to 40 years (both inclusive). 2. Subject willing to refrain from any other treatment of Acne Scarring during entire study duration. 3. Non-pregnant, non-lactating females who agree to use adequate and acceptable methods of contraception from screening and throughout the course of the study. 4. Subjects who are willing to give informed consent and adhere to the study protocol.
Exclusion criteria
Exclusion criteria: 1. Subjects with active infection or active acne. 2. Subjects receiving treatment: NSAIDs treatment within the last 7 days prior to the study. 3. Subjects with history of connective tissue disease. 4. Subjects with metabolic or hematopoietic disorders. 5. Subjects with known bleeding disorders such as platelet dysfunction syndrome, thrombocytopenia, hypofibrinogenemia. 6. Subjects who have received prior chemotherapy and radiotherapy 7. Subjects unwilling to or unable to comply with the study protocol. 8. Subjects taking concomitant therapy that might interfere with the study results in the investigatorâ??s opinion or participating in another trial in the past 30days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢Changes in the Global Acne scarring classification scores from screening to end of the study.Timepoint: End of study - 4 Months | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Photographic Assessment â?¢ Physicianâ??s assessment scores for acne scarring. â?¢ Patientâ??s assessment scores for acne scarring. Timepoint: End of study - 4 Months | — |
Countries
India
Contacts
Public ContactDr Kaushal Shah
Dermocosmetic laser center hair and skin clinic
Outcome results
None listed